Chief exec of Nottingham life sciences firm steps down

Geoffrey Hamilton-Fairley
The founder of Nottingham-based Oncimmune, the early-detection cancer company, is stepping down from his role as chief executive The company has appointed Adam Hill as its new CEO, with founder Geoffrey Hamilton-Fairley moving into a new role as vice chairman. Hill joined Oncimmune as chief medical officer and chief scientific officer and executive director earlier this year from McLaren Applied Technologies and has been leading both the R&D team and a strategic review of the company. Hamilton-Fairley, an early pioneer in... You can carry on reading for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...